CREDIT SUISSE AG/ - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 79 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
6
-99.9%
0.00%
Q3 2021$216,0006,9500.00%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Orbimed Advisors 10,909,256$33,709,6010.72%
Boxer Capital, LLC 2,495,018$7,709,6060.41%
Sio Capital Management, LLC 350,000$1,081,5000.34%
Baker Brothers Advisors 10,123,824$31,282,6160.18%
EcoR1 Capital, LLC 1,157,452$3,576,5270.12%
GSA CAPITAL PARTNERS LLP 70,583$2180.02%
Pale Fire Capital SE 30,781$95,1130.01%
Woodline Partners LP 200,000$618,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 143,957$444,8270.00%
EXCHANGE TRADED CONCEPTS, LLC 32,907$101,6830.00%
View complete list of PRELUDE THERAPEUTICS INC shareholders